Lisdexamfetamine Dimesylate Capsule
Amneal Pharmaceuticals · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 07/14/2023
- Package NDC
- 65162-026-09
- Generic name
- Lisdexamfetamine Dimesylate Capsule
- Contact info
- 866-525-7270
- Availability
- Available
- Update date
- 10/06/2026
- Dosage form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09)
- Company name
- Amneal Pharmaceuticals
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA202830
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE
- Manufacturer name
- Amneal Pharmaceuticals LLC
- Product NDC
- 65162-026, 65162-023, 65162-024, 65162-025, 65162-027, 65162-028
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854834, 854838, 854842, 854846, 854850
- SPL ID
- 4cc5e658-25c6-4a58-a93a-6e35242d6de4
- SPL set ID
- c11cb3b6-3dff-477b-a249-b4c3118edc5f
- Package NDC
- 65162-023-09, 65162-024-09, 65162-025-09, 65162-026-09, 65162-027-09, 65162-028-09
- UNII
- SJT761GEGS